While Johnson & Johnson has been cleared to acquire Synthes, it must sell its wrist fractures unit, known as DVR, to Biomet. The FTC concluded, without this stipulation, Johnson & Johnson and Synthes would control 70 percent of the market for the wrist fracture treatment systems and harm competition.
Related Articles on Orthopedic Devices:
Mazor Launches C-Onsite Spinal Implant Verification Software on Global Scale
Premier Healthcare Alliance Announces New Agreements for Spinal Implants
Orthofix Resolves Alleged False Claims With $34M Settlement
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
